LEMBOREXANT

UNII:	0K5743G68X
Formula:	C₂₂H₂₀F₂N₄O₂
Preferred Substance Name:	LEMBOREXANT
InChIKey:	MUGXRYIUWFITCP-PGRDOPGGSA-N

1369764-02-2
(1R,2S)-2-(((2,4-DIMETHYLPYRIMIDIN-5-YL)OXY)METHYL)-2-(3-FLUOROPHENYL)-N-(5-FLUOROPYRIDIN-2-YL)CYCLOPROPANECARBOXAMIDE
(1R,2S)-2-((2,4-DIMETHYLPYRIMIDIN-5-YL)OXYMETHYL)-2-(3-FLUOROPHENYL)-N-(5-FLUOROPYRIDIN-2-YL)CYCLOPROPANE-1-CARBOXAMIDE
CYCLOPROPANECARBOXAMIDE, 2-(((2,4-DIMETHYL-5-PYRIMIDINYL)OXY)METHYL)-2-(3-FLUOROPHENYL)-N-(5-FLUORO-2-PYRIDINYL)-, (1R,2S)-
DAYVIGO
DEA NO. 2245
E2006
E-2006
LEMBOREXANT [INN]
LEMBOREXANT [JAN]
LEMBOREXANT [MI]
LEMBOREXANT [ORANGE BOOK]
LEMBOREXANT [USAN]
LEMBOREXANT [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LEMBOREXANT

Synonyms and Mappings

Resources